Dyne Therapeutics, Inc. Common Stock (DYN) is a publicly traded Healthcare sector company. As of September 16, 2026, DYN trades at $17.26 with a market cap of $3.46B and a P/E ratio of -5.00. DYN moved -3.21% today. Year to date, DYN is -8.49%; over the trailing twelve months it is +39.19%. Its 52-week range spans $6.36 to $27.31. Analyst consensus is strong buy with an average price target of $37.46. Rallies surfaces DYN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for DYN, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $17.26 |
| Market Cap | $3.46B |
| P/E Ratio | -5.00 |
| EPS | $-3.47 |
| Dividend Yield | 0.00% |
| 52-Week High | $27.31 |
| 52-Week Low | $6.36 |
| Volume | 1.34M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-446.21M |
| Gross Margin | 0.00% |
15 analysts cover DYN: 0 strong buy, 14 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $37.46.